tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Leuchten, 6 are a BUY (30%), 11 are a HOLD (55%), 3 are a SELL (15%).
Analyst Michael Leuchten, currently employed at UBS, carries an average stock price target met ratio of 50% that have a potential upside of 12.93% achieved within 287 days.
Michael Leuchten’s has documented 35 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 12-Jul-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 2/11/2021. The price target of $34.53 was fulfilled within 1 day with a profit of $0.59 (1.74%) receiving and performance score of 17.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$87
$2.47 (2.92%)
$78
11 months ago
(17-Nov-2024)
8/9 (88.89%)
$24.91 (40.12%)
639
Buy
$88
$3.47 (4.11%)
$82
11 months 5 days ago
(12-Nov-2024)
4/5 (80%)
$24.05 (37.61%)
315
Buy
$95
$10.47 (12.39%)
$66
1 years 2 months 6 days ago
(12-Aug-2024)
6/7 (85.71%)
$14.17 (17.53%)
501
Buy
$85
$0.47 (0.56%)
$80
1 years 4 months 18 days ago
(30-May-2024)
4/4 (100%)
$10.26 (13.73%)
414
Buy
$84
$-0.53 (-0.63%)
$85
1 years 5 months 26 days ago
(22-Apr-2024)
2/12 (16.67%)
$15.73 (23.04%)
170
What Year was the first public recommendation made by Michael Leuchten?
